Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Healthcare Business Review: L’Oreal’s FDA WARNING, Dara’s SWISS Deal
Wall Street Cheat Street
Saturday, September 15, 2012 - 9:37am
tags:
L’Oreal, Neuralstem, DARA Biosciences
7 Rallying Biotech Stocks Being Snapped Up By Hedge Funds
Seeking Alpha
Saturday, September 15, 2012 - 9:30am
tags:
Achillion, Affymax, Alexion, Jazz Pharmaceuticals, ONYX Pharmaceuticals, Threshold Pharmaceuticals, ViroPharma
Amgen Inc: Today's Featured Health Care Laggard
The Street
Saturday, September 15, 2012 - 9:29am
tags:
Amgen
Celgene Corporation: Today's Featured Drugs Winner
The Street
Saturday, September 15, 2012 - 9:28am
tags:
Celgene
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner
The Street
Saturday, September 15, 2012 - 9:27am
tags:
Regeneron
Uber-Blockbuster Potential Of Acadia's Pimavanserin: First-In-Class, Next-Generation Antipsychotic
Seeking Alpha
Saturday, September 15, 2012 - 9:26am
tags:
Acadia
Wall Street Transcript Interview with Boris Peaker of Oppenheimer & Company: Emerging-Growth Opportunities in Oncology Biotech
Yahoo/Wall St Transcript
Saturday, September 15, 2012 - 9:24am
tags:
PDL BioPharma Completes Regular Quarterly Dividend Payment
Yahoo/PR Newswire
Saturday, September 15, 2012 - 9:23am
tags:
PDL Biopharma
Biogen Idec Reaches New 52-Week High (BIIB)
The Street
Saturday, September 15, 2012 - 9:18am
tags:
Biogen
Amgen drops after analyst says sales of key drug may disappoint Street
Yahoo/The Fly On The Wall
Saturday, September 15, 2012 - 9:17am
tags:
Amgen
Titan Enters Exclusive Talks To Partner Probuphine
Seeking Alpha
Saturday, September 15, 2012 - 9:16am
tags:
Titan Pharmaceuticals, Probuphine, opioid addiction
Gilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis Drugs for Future
Minyanville
Friday, September 14, 2012 - 12:23pm
tags:
Gilead, HIV, hepatitis C, GS-7977, Truvada
Prednisporin: A Well-Kept Secret
Seeking Alpha
Friday, September 14, 2012 - 12:14pm
tags:
Zalicus, Prednisporin, Merck, Novartis, Pfizer, Sanofi, Allergan
Valeant: Ready To Leap Long-Term On Latest Acquisition
Seeking Alpha
Friday, September 14, 2012 - 11:57am
tags:
M&A, Valeant Pharmaceuticals, Medicis, Teva Pharmaceuticals, Watson Pharmaceuticals
Fast-growing generics maker Perrigo moves into pet care
Fierce Pharma
Friday, September 14, 2012 - 11:55am
tags:
Perrigo, M&A
Boehringer Ingelheim lets Facebook game loose
Fierce Pharma
Friday, September 14, 2012 - 11:54am
tags:
Boehringer Ingelheim, social media, Facebook, Syrum
Pharmaceutical giant Merck & Co. to leave ALEC
Newark Star-Ledger, NJ
Friday, September 14, 2012 - 11:53am
tags:
Merck, ALEC
American drug firm Mylan in talks for a juicy piece of SMS Pharma
Financial Express, India
Friday, September 14, 2012 - 11:52am
tags:
Mylan, India, SMS Pharma, M&A
Biogen Sells Benlysta Rights
Yahoo/Zacks
Friday, September 14, 2012 - 11:51am
tags:
Biogen, Benlysta, GSK
Impax says its generic version of Concerta will go on sale in July 2013 in settlement with J&J
Yahoo/AP
Friday, September 14, 2012 - 11:49am
tags:
Impax, generics, Concerta, JNJ, ADHD, Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.